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Summary
. In 2016, 964 children and young people aged less
than 18 years were receiving long-term renal
replacement therapy (RRT) for established renal
failure (ERF) at UK paediatric nephrology centres.
. A total of 125 incident patients under 18 years com-
menced RRT.
. At the census date (31 December 2016), 77% of
prevalent paediatric patients aged ,16 years had a
functioning kidney transplant (43% live and 34%
deceased donor), 12% were receiving haemodialysis
(HD) and 11% were receiving peritoneal dialysis
(PD).
. In 2016, the prevalence of ERF in patients aged less
than 16 years was 64.1 per million age-related popu-
lation (pmarp). The incidence of ERF for 2016 was
9.0 pmarp.
. Using ERA-EDTA Registry classiﬁcation, tubulo-
interstitial disease (which includes congenital/
structural anomalies) accounted for over half of all
primary renal diagnoses in prevalent patients, with
a high male : female ratio (3.3 : 1). Over time, there
has been a progressive decline in glomerular disease
as a primary renal cause of ERF.
. Between 2002 and 2016, a third of prevalent chil-
dren in ERF aged three months to 16 years who
were referred early received a pre-emptive trans-
plant. Males and White ethnic children were signiﬁ-
cantly more likely to beneﬁt from pre-emptive
transplantation, adjusting for time-period, age at
RRT start and primary renal diagnosis.
. At the time of transfer to adult services, 89.4% of
patients had a functioning kidney transplant.
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Introduction
The UK Renal Registry (UKRR) routinely collects
demographic, clinical, haematological and biochemical
data for patients receiving long-term renal replacement
therapy (RRT) in UK paediatric nephrology centres. In
collaboration with the British Association for Paediatric
Nephrology (BAPN), this data is analysed and published
within the UKRR’s annual report.
For UK children and adolescents, RRT for established
renal failure (ERF) is managed within one of the thirteen
tertiary paediatric nephrology centres. All centres are
equipped to provide peritoneal dialysis (PD) and haemo-
dialysis (HD). Ten of these centres also perform kidney
transplantation.
Young people aged 16–18 years may be managed in
either paediatric or adult services. This is variable across
the UK and dependent on local practices, social factors
and patient/family wishes. In this chapter, data for
patients aged less than 18 years who are managed within
UK paediatric nephrology centres are described, with a
focus on those aged less than 16 years, as this group
represents a complete cohort. Young people aged 16–18
years who have only ever received nephrology care
from adult centres are not included in the analyses.
In the UK in 2015, the prevalence rate of treated ERF
in children and adolescents aged ,16 years was 62.7 per
million age-related population (pmarp) and the incidence
rate was 10.2 pmarp [1].
The objectives of this chapter are:
1. To describe the UK incidence, prevalence, causes of
ERF and modality of treatment of children, adoles-
cents and young adults on RRT on 31 December
2016
2. To describe trends in (1) over the past 15 years
3. To describe pre-emptive transplantation rates and
survival of children and adolescents on RRT aged
,16 years in the UK.
All 13 paediatric nephrology centres in the UK con-
tribute data to the UKRR, mandated in England by the
NHS service speciﬁcation which requires, ‘paediatric
renal units to submit data comprising the national
renal data set to the UK Renal Registry on all patients
on renal replacement therapy’ [2]. In most cases this is
via an annual extract of a centre’s clinical computer
system which is checked, validated and loaded onto the
UKRR paediatric database. At each return, missing data
items are sought. Centres pay a capitation fee to support
the process. The UKRR is currently moving towards a
more streamlined means of data extraction through the
UK Renal Data Collaboration (UKRDC), which is due
to start receiving and testing extracted 2017 data from
renal servers in the summer of 2018.
Methods
Centres arranged for their own data to be extracted and sent to
the UKRR for processing by clinical informaticians. For 2016, all
centres were using electronic clinical data capture systems: seven
different systems are used among 13 paediatric renal centres.
For this report, data returns were required by 31 March 2017.
However, data were still received by the UKRR until January 2018.
The content and analyses contained in the paediatric chapters
are discussed and agreed by the BAPN Audit and Research
Committee members.
In this report, patient groups are described as:
1. ‘Incident’ group: patients who started RRT between
1 January and 31 December 2016
2. ‘Prevalent’ group: patients who were receiving RRT on
31 December 2016
3. ‘Five-year’ groups: patients who started RRT in the periods
of 2002–2006, 2007–2011 and 2012–2016.
RRT is deﬁned as all patients with renal transplants and
patients on HD and PD for 90 days or more. Dialysis for acute
kidney injury (AKI) is not reported currently. All patients ,16
years of age at the start of RRT are included in these analyses.
The cohort of patients starting RRT aged 516 years of age was
incomplete and includes only those whose treatment was started
in a paediatric centre.
The populations used to calculate incidence and prevalence
were obtained from the Ofﬁce for National Statistics (ONS) [3].
The mid-2016 population estimate produced by the ONS, based
on the 2011 census, was used to calculate the 2016 incidence
and prevalence rate; the 2004 population estimate data were
used for the 2002–2006 group, the 2009 data for the 2007–2011
group and the 2014 data for the 2012–2016 group. Incidence
and prevalence for 16–18-year olds are not reported because
data would not be representative of the UK as these young people
may also be managed in adult services.
Ethnicity is deﬁned as stated by the patient/family and is
reported as White, South Asian, Black and Other. The South
Asian ethnicity includes those of Indian, Pakistani or Bangladeshi
origin only. The Other ethnicity group includes those from
Chinese, other South Asian groups (e.g. Vietnamese, Malaysian),
Arabic, mixed race ethnic origin or any other group. Black ethni-
city includes those of Black-African, Black-Caribbean origin and
Black-other groups.
In previous years, primary renal disease was described accord-
ing to a registry derived grouping system established in 2002 [4].
For ease of coding and increased comparability, a decision was
made to move to 2012 diagnostic groupings used by the ERA-
EDTA Registry: these include tubulointerstitial disease, glomerular
disease, familial and hereditary nephropathies, systemic disease
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affecting the kidney and miscellaneous. Further details on
how primary diagnoses are coded and grouped can be found
on the ERA-EDTA Registry website (www.era-edta-reg.org/
index.jsp?p=37).
Statistical analyses were performed using SAS 9.3, with group
analyses using the chi-squared test and median analyses using
the Kruskal-Wallis test. Infants under the age of three months
and late presenters (deﬁned as those commencing dialysis within
three months following ﬁrst review by a paediatric nephrologist)
were excluded from analyses when calculating pre-emptive
transplantation rates. Multivariable logistic regression was used
to analyse odds of pre-emptive transplantation by age, sex and
other demographic variables. For survival analysis, patients
starting RRT between 1 January 2002 and 31 December 2015
and receiving RRT for at least 90 days were included to ensure a
minimum of one-year follow-up at the census date. These patients
were followed up to a maximum age of 16 years, transfer out of
paediatric service or death; whichever occurred ﬁrst. As the
maximum age of follow-up was restricted to 16 years it was not
possible to calculate 10-year survival probabilities for patients
starting RRT aged over eight years, or ﬁve-year survival probability
for children starting RRT aged over 12 years. A Cox regression
model was used to calculate hazard ratios for patient survival,
adjusting for sex, age at start of RRT and RRT modality as a




Overall data completeness was excellent for the follow-
ing: age and sex (100%), ethnicity (98.7%), start and
90-day treatment modality (99.6%) and start date
(99.4%). Completeness of other data items ranged from
83.5% to 99.4% (table 4.1). Centre size and type (if under-
taking paediatric kidney transplantation) are also dis-
played. Of note, height at RRT has the lowest level of
completeness. While the proportion of missing data is
improving over time, lack of height data at RRT start is
associated with age, which in part may reﬂect difﬁculties
in obtaining measurements for very young children
(,2 years).
The UK paediatric prevalent ERF population in 2016
A total of 964 children and young people aged
,18 years with ERF were receiving treatment at paedia-
tric nephrology centres in 2016 (table 4.1). Of these, 794
(82.4%) were ,16 years of age. Table 4.2 shows the
number of these patients receiving RRT and prevalence
rate by age group and sex. More than ten times the
number of teenagers received RRT compared with
infants. The prevalence of RRT increased with age and
was higher in males across all age groups with an overall
male to female ratio of 1.7 : 1. The reported prevalence in
,16 year olds was 64.1 pmarp.
Table 4.3 shows the prevalence of ERF in children less
than 16 years old by age and ethnic group. A higher
prevalence is again noted for children of ethnic minority.
This was particularly evident for South Asian children
whose prevalence was almost double the overall RRT
prevalence of 64.1 pmarp.













Blfst_P∗ 30 93.3 80.0 90.0 93.3 100.0
Bham_P∗ 112 95.5 92.9 95.5 95.5 98.2
Brstl_P∗ 55 96.4 87.3 94.6 98.2 100.0
Cardf_P 35 94.3 91.4 91.4 94.3 97.1
Glasg_P∗ 60 98.3 81.7 85.0 85.0 100.0
L Eve_P∗ 108 86.1 68.5 75.0 74.1 99.1
L GOSH_P∗ 184 96.7 87.5 94.6 94.6 100.0
Leeds_P∗ 81 100.0 88.9 100.0 100.0 100.0
Livpl_P 55 98.2 78.2 83.6 92.7 100.0
Manch_P∗ 88 96.6 95.5 97.7 97.7 100.0
Newc_P∗ 32 96.9 90.6 90.6 81.3 100.0
Nottm_P∗ 94 95.7 75.5 95.7 96.8 97.9
Soton_P 30 93.3 46.7 46.7 56.7 100.0
UK 964 95.4 83.5 90.3 91.2 99.4
RRT – renal replacement therapy
∗Denotes centres undertaking kidney transplantation for children




Most prevalent paediatric patients under 16 years old
in 2016 had a functioning transplant (77%), as shown
in ﬁgure 4.1. The ratio of living to deceased donor
transplants was 1 : 0.8.
By comparison, 45% of patients started RRT on PD,
33% on HD and 22% with a pre-emptive transplant, as
displayed in ﬁgure 4.2.
Analysis of current treatment modality by age shows
that the majority of patients below the age of four years
were receiving dialysis whilst most children over four
years had a transplant (table 4.4). Transplantation was
not performed in any child under two years of age and
living donor transplants were more common than
deceased donor transplants in those aged two to twelve
years. When comparing current treatment by ethnicity
in 2016, White children were more likely to have a func-
tioning transplant compared with non-White children
(p = 0.003). This ﬁnding however was not age-adjusted
which given the higher proportion of ethnic minorities
Table 4.2. The UK paediatric prevalent ERF population ,16 years old on 31/12/2016, by age group and sex
All patients Males Females
M : F rate
ratioAge group (years) N pmarp N pmarp N pmarp
0–,2 24 15.3 16 19.9 8 10.5 1.9
2–,4 59 36.7 43 52.2 16 20.4 2.6
4–,8 177 53.9 121 72.0 56 34.9 2.1
8–,12 233 75.3 142 89.5 91 60.3 1.5
12–,16 301 106.2 190 130.9 111 80.3 1.6
Under 16 794 64.1 512 80.7 282 46.7 1.7
pmarp – per million age related population
Table 4.3. The UK paediatric prevalent ERF population ,16 years old in 2016, by age and ethnic groupa
Age group (years) White South Asian Black Other
0–,4 53 12 5 9
4–,8 126 21 5 22
8–,12 157 47 10 15
12–,16 220 48 15 16
Under 16 556 128 35 62
pmarp (<16)b 55.6 120.6 64.6 78.4
pmarp – per million age related population
aEthnicity not recorded for 13 children, not included in this table
bpmarp was calculated by assuming the same ethnic distribution for ,16 years old from the 2011 ONS census, applied to the total UK 2016










Fig. 4.1. RRT treatment used by prevalent paediatric patients










Fig. 4.2. Treatment modality at start of RRT in prevalent paedia-
tric patients ,16 years old on 31/12/2016
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aged under four years, may partly explain the differences
seen (data not shown).
Cause of ERF
Tubulointerstitial disease (TID) was the commonest
renal diagnostic group in prevalent patients under 16
years in 2016 (table 4.5), accounting for over half of all
primary renal disease (PRD) diagnoses. The high male
to female ratio for this group (3.33 : 1) likely reﬂects the
number of boys with obstructive uropathy due to
posterior urethral valves. Based on previous reporting
criteria, congenital anomalies of the kidneys and urinary
tract (CAKUT) account for almost all the diagnoses
within this group (99.8%, data not shown). Congenital
nephrotic syndrome accounted for 60% of prevalent
glomerular disease requiring RRT (81 patients). In 2016,
there were 21 prevalent patients receiving RRT due to
malignancy, whilst no patients had a PRD of drug toxicity
(both now coded under ‘miscellaneous’). Primary renal
disease was uncertain or unknown in only 4% of patients.
Overall, White patients constituted 71.2% of the preva-
lent ERF population, but represented 87.9% of patients
with systemic diseases affecting the kidney. This
diagnostic group encompasses conditions such as haemo-
lytic uraemic syndrome (HUS) and renovascular disease.
Prevalent and incident PRD data by historic UKRR
groupings are available for comparison (ﬁgure 4.6 and
table 4.13 in appendix 1 of this chapter).
Figure 4.3 displays the proportion of patients in each
ERA-EDTA diagnostic category for the incident and
prevalent cohorts.





HD PD Live transplant Deceased donor transplant
N % N % N % N %
0–,2 24 7 29.2 17 70.8 0 0.0 0 0.0
2–,4 59 19 32.2 24 40.7 11 18.6 5 8.5
4–,8 177 19 10.7 17 9.6 98 55.4 43 24.3
8–,12 233 26 11.2 10 4.3 113 48.5 84 36.1
12–,16 301 23 7.6 22 7.3 122 40.5 134 44.5
16–,18 170 14 8.2 11 6.5 68 40.0 77 45.3
Under 16 794 94 11.8 90 11.3 344 43.3 266 33.5
Under 18 964 108 11.2 101 10.5 412 42.7 343 35.6
HD – haemodialysis; PD – peritoneal dialysis
Table 4.5. Number and percentage of the prevalent ERF population ,16 years old in 2016, by sex and ethnicity
Diagnostic group N % Males Females Proportion of non-White patients
Tubulointerstitial disease 424 53.4 326 98 26.9
Glomerular disease 134 16.9 65 69 30.8
Familial/hereditary nephropathies 118 14.9 53 65 39.8
Systemic diseases affecting the kidney 34 4.3 18 16 12.1
Miscellaneous 78 9.8 45 33 26.7
Missing 6 0.8 5 1 20.0
























Fig. 4.3. Comparison of PRD groupings in the 2016 UK paedia-
tric incident and prevalent ERF population ,16 years old for
patients with non-missing data
Demography of UK paediatric RRT
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The UK paediatric incident ERF population in 2016
There were 125 patients ,18 years of age who com-
menced RRT at paediatric renal centres in 2016. The
following analyses are restricted to the 112 patients who
were ,16 years of age.
The overall incidence of RRT was 9.0 pmarp in 2016.
Patients commencing RRT in 2016 are displayed by age
and sex in table 4.6; apparent differences may be a result
of small group sizes.
Trends in ERF demographics
There were 1,720 children and adolescents ,16 years
of age who received RRT in the UK between 2002 and
2016. In general, the overall incidence of RRT has
remained steady over the past ten years (table 4.7).
Relative increases in incidence were seen in younger
patients, notably the under two and two to four year
age groups, while a decrease was seen for children aged
12 to ,16 years. Table 4.8 shows a decrease in the
Table 4.6. The UK paediatric incident ERF population ,16 years old in 2016, by age group and sex
Age group (years)
All patients Males Females
N pmarp N pmarp N pmarp
0–,2 24 15.3 14 17.4 10 13.1
2–,4 8 5.0 7 8.5 1 1.3
4–,8 17 5.2 12 7.1 5 3.1
8–,12 25 8.1 15 9.5 10 6.6
12–,16 38 13.4 17 11.7 21 15.2
Under 16 112 9.0 65 10.2 47 7.8
pmarp – per million age related population
Table 4.7. Reported numbers and average incidence by age group in ﬁve-year time periods of the UK paediatric incident ERF
population ,16 years old commencing RRT
Age group (years)
2002–2006 2007–2011 2012–2016
N pmarp N pmarp N pmarp
0–,2 77 11.1 100 12.7 112 14.2
2–,4 33 4.9 59 7.8 75 9.1
4–,8 89 6.2 89 6.4 113 7.1
8–,12 109 7.3 129 9.0 136 9.4
12–,16 210 13.4 213 14.0 176 12.3
Under 16 518 8.8 590 10.0 612 10.1
pmarp – per million age related population
Table 4.8. Number∗ and percentage of the UK paediatric incident ERF population ,16 years old who commenced RRT, by
ethnicity and ﬁve-year period of starting RRT
Ethnic group
2002–2006 2007–2011 2012–2016
N % N % N %
White 409 79.4 432 74.1 411 68.6
South Asian 77 15.0 95 16.3 104 17.4
Black 14 2.7 27 4.6 23 3.8
Other 15 2.9 29 5.0 61 10.2
Under 16 515 583 599
∗Three children in 2002–2006, seven in 2007–2011 and 13 in 2012–2016 with no ethnicity recorded are excluded from this table
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proportion of White ethnic and an increase in Other
ethnic group patients starting RRT over the same time
periods. Table 4.9 shows that the overall proportions
between paediatric renal centres have ﬂuctuated only
slightly over this period.
The proportion of patients starting RRT with deceased
donor transplants fell (from 13.4% in 2002–2006 to 7.7%
in 2012–2016, ﬁgure 4.4) with total numbers down by
30% over this time. Living donor transplantation as a
start modality has seen small increases during this period.
The proportion of PD use at RRT start continued to fall,
having dropped from 48.5% in 2002–2006 to 37.9% in
2012–2016. This reduction is offset mainly by increased
use of HD, with patient numbers having almost doubled
since 2002–2006 (122 to 228 patients).
The proportion of patients with glomerular disease as
a cause of ERF in the prevalent paediatric population
has fallen over the last 15 years (table 4.10). Numbers
of incident patients commencing chronic RRT for conge-
nital nephrotic syndrome over this time period however
have almost doubled (see appendix 1, table 4.13).
Pre-emptive transplantation
Of the 1,720 patients aged,16 years who started RRT
between 2002 and 2016, 454 were excluded from this
analysis (94 patients due to being aged under three
Table 4.9. Number and percentage of the UK paediatric incident ERF population ,16 years old, by renal centre and ﬁve-year
period of starting RRT
Centre
2002–2006 2007–2011 2012–2016
N % N % N %
Blfst_P 14 2.7 26 4.4 15 2.5
Bham_P 54 10.4 61 10.3 71 11.6
Brstl_P 35 6.8 35 5.9 31 5.1
Cardf_P 20 3.9 15 2.5 24 3.9
Glasg_P 30 5.8 47 8.0 38 6.2
L Eve_P 43 8.3 70 11.9 69 11.3
L GOSH_P 101 19.5 114 19.3 111 18.1
Leeds_P 51 9.8 47 8.0 55 9.0
Livpl_P 30 5.8 22 3.7 34 5.6
Manch_P 50 9.7 46 7.8 66 10.8
Newc_P 26 5.0 25 4.2 25 4.1
Nottm_P 46 8.9 62 10.5 58 9.5
Soton_P 18 3.5 20 3.4 15 2.5
Under 16 518 590 612

























Fig. 4.4. Treatment modality at start of RRT
for the UK paediatric incident ERF
population ,16 years old, by ﬁve-year
time-period
Demography of UK paediatric RRT
population
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months, 360 due to being late presenters). Table 4.11
shows that one third of included patients (N = 1,266)
received a pre-emptive transplant.
A signiﬁcant difference exists in pre-emptive trans-
plantation rates by sex, with higher rates seen in boys
(p = 0.001); this difference persisted (p = 0.002) when
adjusted for time-period, ethnicity, age at RRT start
and PRD in a logistic regression. Signiﬁcantly higher
rates were also seen in White patients (versus non-
White ethnicity, p =,0.0001). As expected, fewer pre-
emptive transplantations were performed in very young
patients (,2 years). When children under two years
were excluded from analysis, a signiﬁcant difference in
pre-emptive transplantation rates between age groups
persisted (p = 0.02), however this was not signiﬁcant
when assuming a linear correlation with age (p = 0.2)
using the Mantel-Haenszel test.
Pre-emptive transplantation rates differed by PRD
according to ERA-EDTA registry groupings (p =
0.0001); the lowest rates were seen in patients with
glomerular or miscellaneous disease.
Transfer of patients to adult renal services in 2016
Ninety patients transitioned to adult renal services in
2016, similar to the 85 who transferred during 2015.
The median age of patients at transfer was 18.0 years
with an inter-quartile range of 17.7–18.3 years. Overall,
the demographics of this population reﬂected those of
the prevalent paediatric RRT population, but with a
higher proportion having a functioning transplant
(89.4% versus 77.0%).
Survival of children on RRT during childhood
Of patients under 16 years of age, 1,575 started RRT
between 2002 and 2015 at paediatric centres in the UK
and were included in survival analyses. At the census
date (31 December 2016) there were 75 deaths reported
in children aged ,16 years, which is the same number
as for 2015. The median follow up time (beyond day
90) was 3.3 years (range three days to 14.6 years).
Table 4.12 shows the survival hazard ratios by age at
start of RRT, sex and RRT modality and highlights that
very young children (,2 years) at RRT start had the
worst survival outcomes, when compared to 12–16 year
olds. Being on dialysis has again shown to lower survival
Table 4.11. Demographic characteristics of pre-emptive trans-
plantation in the UK paediatric ERF population aged three
months to 16 years, 2002–2016, by ﬁve-year time-period, sex,





Total cohort analysed (2002–2016) 1,266 423 (33.4)
Time period
2002–2006 393 130 (33.1)
2007–2011 410 144 (35.1)
2012–2016 463 149 (32.2)
Sex
Male 797 287 (36.0)
Female 469 136 (29.0)
Ethnicity
White 918 337 (36.7)
South Asian 207 48 (23.2)
Other 76 24 (31.6)
Black 45 7 (15.6)
Age at start of RRT (years)
3 months–,2 141 8 (5.7)
2–,4 144 39 (27.1)
4–,8 232 99 (42.7)
8–,12 291 103 (35.4)
12–,16 458 172 (38.0)
Primary renal diagnosis
Tubulointerstitial disease 678 295 (43.5)
Glomerular disease 245 19 (7.8)
Familial/hereditary nephropathies 195 65 (33.3)
Miscellaneous renal disorders 91 24 (26.4)
Systemic diseases affecting the kidney 44 17 (38.6)
Table 4.10. Number∗ and percentage of primary renal diseases in the UK paediatric prevalent ERF population ,16 years old, by
ﬁve-year time-period
2002–2006 2007–2011 2012–2016 2002–2016
Primary renal diagnosis N % N % N % % change
Tubulointerstitial disease 259 50.5 284 48.6 310 51.1 0.6
Glomerular disease 116 22.6 115 19.7 104 17.1 −5.5
Familial/hereditary nephropathies 78 15.2 102 17.5 98 16.1 0.9
Systemic diseases affecting the kidney 14 2.7 34 5.8 22 3.6 0.9
Miscellaneous renal disorders 46 9.0 49 8.4 73 12.0 3.1
∗Five children in 2002–2006, six in 2007–2011 and ﬁve in 2012–2016 with no primary renal diagnosis recorded are excluded from this table
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signiﬁcantly compared to having a functioning trans-
plant, with a hazard ratio of 7.4 (CI 3.9–14.1,
p, 0.0001). Figure 4.5 shows unadjusted Kaplan-Meier
survival probabilities and demonstrates worse outcomes
for children aged less than two years, particularly in the
ﬁrst 12 months. By comparison, children and young
people aged 8–16 years have very good one year survival
rates, with no deaths reported.
Mortality data in 2016
Ten deaths occurred in children under 16 years in
2016; the median age at death was 7.7 years (range 0.4–
15.5 years). In children aged ,16 years with treated
ERF, the reported mortality in UK paediatric centres
was 1.3% (10/794).
Transplant deaths
One patient had a functioning kidney transplant at
time of death. The cause of death was unexplained.
Dialysis deaths
In 2016, six patients were on dialysis at time of death
(three PD, three HD). One patient died of malignancy,
one of pancreatitis, two of septicaemia and another due
to cardiac failure secondary to a metabolic disorder.
Cause of death was not established in one patient.
Three further patients had dialysis withdrawn due to
medical (non-renal) reasons.
Discussion
This report continues to provide important insights
into the demography of UK children and young people
on long-term RRT with comparison of trends over
time. Information gleaned from the registry is not only
vital for planning and ﬁnancing tertiary services but has
the potential to facilitate translation of research into
clinical practice, thus driving improvements in patient
care [5]. Moreover, moving towards a more standardised
method of coding for primary renal disease, further com-
parisons with international registries will be possible.
Data returns
One of the key aims of the UKRR is to provide con-
temporaneous epidemiological data on the paediatric
RRT cohort. This is dependent on centres submitting
data to the UKRR in a timely fashion, thus allowing
Table 4.12. Survival hazard ratio during childhood for the UK
paediatric ERF population ,16 years old, for age at start of







0–,2 years 3.0 1.3–6.9 0.012
2–,4 years 2.0 0.7–5.4 0.18
4–,8 years 2.2 0.9–5.5 0.08
8–,12 years 1.0 0.3–2.7 0.9
12–,16 years 1.0
Sex
Female 1.1 0.7–1.7 0.7
Male 1.0
RRT modality
Dialysis 7.4 3.9–14.1 ,0.0001
Transplant 1.0

















Age 12–<16 Fig. 4.5. Unadjusted Kaplan-Meier
survival in the UK paediatric ERF
population ,16 years old starting RRT
between 2002 and 2015, by age at start
Demography of UK paediatric RRT
population
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thorough data checks and validation to occur prior to
analysis.
For the paediatric dataset, this process has its own
inherent challenges and limitations. Firstly, some renal
computer systems extract adult and paediatric data
together despite differences in the data ﬁelds requested,
which results in requests for additional paediatric data
from centres. Secondly, important missing data ﬁelds
that have not been automatically populated by local
systems require contact with lead clinicians in each centre
to ‘ﬁll in the gaps’. Understandably, this can cause a delay
in data cleaning and validation while placing an additional
burden on busy clinical teams. Suggestions on how to
improve and streamline this process are welcomed.
Highlights from the 2016 data
Overall, there has been little change in the reported
age-adjusted prevalence and incidence of the paediatric
RRT population. Teenagers account for a high proportion
of the prevalent population, although their incidence
remained stable over time. Conversely, children under
two years accounted for a small proportion of the preva-
lent population in 2016 (3%), yet incident numbers start-
ing chronic RRT were increasing year-on-year. Based on
2016 population census ﬁgures, ethnic minorities contin-
ued to record a high prevalence of patients on RRT, with
South Asian ethnicity accounting for the highest.
Most prevalent patients had a functioning transplant
which is encouraging, further still was the high pro-
portion of young people transitioning to adult care
dialysis-free (89.4%). As expected, high proportions of
younger children (,4 years) were reliant on dialysis,
with few receiving a kidney transplant.
As reported in the last audit, less than a quarter of UK
children commencing RRT received a pre-emptive trans-
plant, with disparities seen amongst the sexes and ethnic
groups despite adjusting for potential confounders. Sex
differences in paediatric access to transplantation echo
ﬁndings reported by the ERA-EDTA Renal Registry:
females were 23% less likely than males to receive a
pre-emptive transplant with medical factors explaining
only 70% of the variation seen [6]. This analysis was
unable to account for non-clinical characteristics such
as socio-economic status (SES). In addition, the US
Renal Data System has reported reduced access to living
donor pre-emptive transplantation in ethnic minorities,
with black patients 66% and Hispanics 52% less likely
to beneﬁt from pre-emptive transplantation, despite
adjustment for SES [7]. An analysis of UKRR data to
explore whether SES is associated with access to pre-
emptive transplantation has been approved and is
planned for this coming year.
RRT start modality
PD remained the most popular start modality in 2016,
used in just under half of all patients commencing RRT.
Over time however, its use and that of deceased donor
transplantation is falling, with concurrent increases in
HD use seen. When analysed by time-period, the
numbers of patients starting on HD and PD for 2012–
2016 were similar (228 versus 232 respectively). Whilst
living donor transplantation is increasing over time, the
reason for the noticeable increases in HD use (over PD
or deceased donor transplantation) is unclear and
requires further investigation.
Primary renal disease
This year, the UKRR paediatric dataset has moved to
the 2012 ERA-EDTA diagnostic grouping system to
categorise primary renal disease. However, reference
to previous UKRR groupings is made. Tubulointerstitial
disease, which encompasses structural and congenital
anomalies, accounts for over half of all prevalent cases
of ERF.
Numbers of patients with glomerular disease as a
primary cause for ERF is falling over time. As the
UKRR expands to collect data on patients with earlier
pre-dialysis stages of CKD (4 and 5), understanding
will increase as to whether this observation is due to
improved disease control or a true reduction in disease
leading to glomerular pathology. It is also noted that
fewer patients with glomerular or miscellaneous disease
are pre-emptively transplanted. As these groupings may
encompass disease processes with a rapid decline in
function (miscellaneous includes codes for acute kidney
injury), this may preclude patients from early transplan-
tation.
Comorbidity
Reporting of comorbidities in the paediatric RRT
population has been challenging for some time. Data
completeness remained low and recorded comorbidity
varied greatly between centres. This has led to concerns
regarding the representativeness of the burden of disease
faced by the paediatric nephrology community. In view of
this, and in eager anticipation of ﬁndings from the 2016–
2017 BAPN comorbidities audit, it was decided that
UKRR collated information would not be included in
this year’s report. Furthermore, research is planned
that aims to compare and validate UKRR recorded
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comorbidity with Hospital Episode Statistics (HES) data,
thus enhancing our knowledge of this cohort.
Survival
Survival data from the UKRR continued to show the
negative effect of younger age on mortality risk and
medium-term survival compared with older age groups.
Dialysis use also confers substantial mortality risk. A
recent UK publication describing survival of young
people aged 11–30 years reinforces these ﬁndings and
highlights that this risk is further ampliﬁed for patients
who are not wait-listed for transplant (HR 16.6, 95%
CI 10.8–25.4, p =,0.0001) [8]. Although few paediatric
deaths are reported each year, it is becoming apparent
that cause of death, often due to a complex interaction
between renal and extra-renal factors, in many cases is
not fully captured by a single code-reporting system. A
BAPN-UKRR audit of RRT deaths is planned this year
to ascertain how best to collect and report this data for
audit and research purposes.
Current and future work
Several paediatric based projects are underway or
planned in collaboration with the UK Renal Registry
this coming year. It is encouraging to note that of the sub-
mitted applications to the UKRR for data in 2017–2018,
half are paediatric based or include a paediatric element.
Several projects have been developed jointly with the
BAPN. The need for improved comorbidity reporting
in the RRT cohort has led to the development and com-
pletion of a UK-wide survey by paediatric nephrology
centres. Results have now been received by the UKRR,
with a report of ﬁndings expected later this year.
Another BAPN-UKRR project is planned for later this
year which will audit cause of death data for RRT patients
with paediatric centre-held medical records. As pre-
viously described, the aims of this project are to 1) under-
stand risk factors for death by age and disease group and
2) determine whether current coding systems accurately
capture cause of death for the paediatric population.
As the UKRR expands its dataset to include patients
under pre-dialysis care, little is known about children
who develop ERF but in whom a decision is made not
to pursue renal replacement therapy. It is not clear
whether these children are known to nephrology services,
what factors are implicated in the decision for conserva-
tive management, or whether decisions regarding life-
sustaining treatment are made in accordance with
national and international guidance. An initial proposal
to explore this issue in greater detail has been submitted
and approved by the British Paediatric Surveillance Unit
(BPSU). It is hoped this prospective study will provide a
more accurate picture of childhood ERF in the UK and
will also inform future data collection through the UKRR.
Approved paediatric/young adult research projects
using UKRR data include an analysis of risk factors impli-
cated in graft survival and rate of function decline post-
transplantation; exploring the association of non-clinical
variables in timing and access to specialist services and an
analysis of the beneﬁts of transplant versus dialysis for
children using a marginal structural modelling approach.
A follow-up report on children who commenced dialysis
aged less than two years is also planned.
Applications are welcomed for paediatric and young
adult research projects using UKRR data. Further details
regarding the application process can be found on the
UKRR website: www.renalreg.org/about-us/working-
with-us/.
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Appendix 1: Historic UKRR diagnostic groupings
Table 4.13. Number and percentage of children under 16 years for whom a primary renal diagnosis had been reported as a cause
of ERF (using historic UKRR groupings), by 5-year time period
2002–2006 2007–2011 2012–2016
Primary renal diagnosis N % N % N %
Congenital nephrotic syndrome 25 4.9 35 6.0 49 8.1
Glomerular disease 103 20.1 118 20.2 74 12.2
Polycystic kidney disease 15 2.9 19 3.3 22 3.6
Metabolic 21 4.1 31 5.3 28 4.6
Obstructive uropathy 83 16.2 95 16.3 204 33.6
Renal dysplasia + reﬂux 168 32.7 181 31.0 105 17.3
Tubulo-interstitial diseases 42 8.2 49 8.4 44 7.2
Malignancy & associated disease 11 2.1 6 1.0 16 2.6
Uncertain aetiology 26 5.1 25 4.3 41 6.8
Drug nephrotoxicity 6 1.2 3 0.5 0 0.0
Renovascular disease 13 2.5 22 3.8 24 4.0
Total 513 584 607
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Fig. 4.6. Proportion of primary renal disease by historic UKRR
diagnostic groupings in incident and prevalent paediatric patients
in 2016 for whom a causative diagnosis was reported
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